Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Patheon

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ACETAZOLAMIDE SODIUM

    02 1ALTEPLASE

    03 1Abatacept

    04 2Basiliximab

    05 1COLISTIMETHATE SODIUM

    06 1Cangrelor

    07 2Carfilzomib

    08 1Coagulation factor ix (recombinant)

    09 1Colesevelam Hydrochloride

    10 2Daptomycin

    11 10EFMOROCTOCOG ALFA

    12 1ERAVACYCLINE DIHYDROCHLORIDE

    13 1ETANERCEPT, LICENSE HOLDER UNSPECIFIED

    14 1FOSAPREPITANT DIMEGLUMINE

    15 1Glycerol phenylbutyrate

    16 1Infliximab, License Holder Unspecified

    17 2LUSPATERCEPT

    18 1MELPHALAN HYDROCHLORIDE

    19 1Metaraminol Bitartrate

    20 1Neostigmine Methylsulfate

    21 1OZANIMOD HYDROCHLORIDE

    22 1Opicapone

    23 1PANTOPRAZOLE SODIUM

    24 1Pyridostigmine Bromide

    25 1RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN

    26 1REMDESIVIR

    27 1Rezafungin

    28 2Risperidone

    29 2SOTATERCEPT-CSRK

    30 1TICAGRELOR

    31 1TOBRAMYCIN SULFATE

    32 1TRASTUZUMAB

    33 1Thrombin, topical (Recombinant)

    34 1Tigecycline

    35 1VIGABATRIN

    36 1Vedolizumab

    37 1bivalirudin

    38 1certolizumab pegol

    39 3coagulation factor IX (recombinant)

    40 1delafloxacin meglumine

    41 2elotuzumab

    42 1eravacycline dihydrochloride

    43 1ethacrynate sodium

    44 1hexaminolevulinate hydrochloride

    45 1imetelstat sodium

    46 1indocyanine green

    47 1infliximab

    48 1omadacycline

    49 1oritavancin

    50 1oritavancin diphosphate

    51 1oseltamivir phosphate

    52 1remdesivir

    53 1remimazolam besylate

    54 1reteplase

    55 3romiplostim

    56 1sodium phenylbutyrate and ursodoxicoltaurine

    57 1tedizolid phosphate

    58 1trastuzumab

    59 1triamcinolone acetonide

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    ABATACEPT

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    ABATACEPT

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 68225-241

    Start Marketing Date : 2022-07-17

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (250mg/15mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    ACETAZOLAMIDE SODIUM

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    ACETAZOLAMIDE SODIUM

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 63552-116

    Start Marketing Date : 2013-12-10

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (500mg/5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    ALTEPLASE

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    ALTEPLASE

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 63552-041

    Start Marketing Date : 2001-09-04

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (2.2mg/2mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    BASILIXIMAB

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    BASILIXIMAB

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 68225-238

    Start Marketing Date : 1998-05-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (20mg/5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    BASILIXIMAB

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    BASILIXIMAB

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 68225-237

    Start Marketing Date : 1998-05-12

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (10mg/2.5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    BIVALIRUDIN

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    BIVALIRUDIN

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 68225-041

    Start Marketing Date : 2000-12-15

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (250mg/5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    CANGRELOR

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    CANGRELOR

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 68225-062

    Start Marketing Date : 2015-07-08

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (50mg/1)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    CARFILZOMIB

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    CARFILZOMIB

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 63552-035

    Start Marketing Date : 2012-07-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (30mg/15mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    CARFILZOMIB

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    CARFILZOMIB

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 63552-009

    Start Marketing Date : 2012-07-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (60mg/30mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    CERTOLIZUMAB PEGOL

    U.S.A
    Fi Europe 2024
    Not Confirmed
    arrow

    CERTOLIZUMAB PEGOL

    U.S.A
    arrow
    Fi Europe 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Patheon

    NDC Package Code : 68225-045

    Start Marketing Date : 2008-04-20

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (200mg/mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Contact Patheon and get a quotation

    Patheon is a supplier offers 11 products (APIs, Excipients or Intermediates).

    Find a price of Pyridostigmine bulk with CEP, JDMF offered by Patheon

    Find a price of Clodronic Acid Disodium Salt bulk with CEP offered by Patheon

    Find a price of Fostamatinib Disodium Hexahydrate bulk with JDMF offered by Patheon

    Find a price of Neostigmine Bromide bulk with JDMF offered by Patheon

    Find a price of Neostigmine Methylsulfate bulk with CEP offered by Patheon

    Find a price of Patiromer Sorbitex Calcium bulk with JDMF offered by Patheon

    Find a price of Vitamin E bulk with JDMF offered by Patheon

    Find a price of Latanoprost bulk offered by Patheon

    Find a price of MANUFACTURING SITE, FACILITIES AND PERSONNEL IN FORT ERIE, ONTARIO, CANADA bulk offered by Patheon

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MISSISSAUGA, ONTARIO, CANADA. bulk offered by Patheon

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BURLINGTON, ONTARIO, CANADA. bulk offered by Patheon